{"type":"rich","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fctd-gim.hatenablog.com%2Fentry%2F2019%2F10%2F09%2F172544\" title=\"\u5076\u767a\u6027\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u9593\u8cea\u6027\u80ba\u75be\u60a3\u3068\u30e1\u30c8\u30c8\u30ec\u30ad\u30b5\u30fc\u30c8\u6cbb\u7642\u306e\u95a2\u9023 - \u81a0\u539f\u75c5\u30fb\u30ea\u30a6\u30de\u30c1\u4e00\u4eba\u6284\u8aad\u4f1a\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","width":"100%","url":"https://ctd-gim.hatenablog.com/entry/2019/10/09/172544","categories":[],"description":"Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts BMJ Open. 2019; 9(5): e028466. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501950/ \u30aa\u30fc\u30d7\u30f3\u30b8\u30e3\u30fc\u30ca\u30eb\u3067\u306f\u3042\u308b\u304c\u3001\u7d50\u69cb\u9762\u767d\u3044\u8ad6\u6587\u3060\u3068\u601d\u3063\u305f\u306e\u3067\u7d39\u4ecb\u3002","author_name":"CTD_GIM","blog_title":"\u81a0\u539f\u75c5\u30fb\u30ea\u30a6\u30de\u30c1\u4e00\u4eba\u6284\u8aad\u4f1a","image_url":"https://cdn-ak.f.st-hatena.com/images/fotolife/C/CTD_GIM/20191009/20191009170713.jpg","version":"1.0","author_url":"https://blog.hatena.ne.jp/CTD_GIM/","height":"190","blog_url":"https://ctd-gim.hatenablog.com/","provider_name":"Hatena Blog","provider_url":"https://hatena.blog","published":"2019-10-09 17:25:44","title":"\u5076\u767a\u6027\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u9593\u8cea\u6027\u80ba\u75be\u60a3\u3068\u30e1\u30c8\u30c8\u30ec\u30ad\u30b5\u30fc\u30c8\u6cbb\u7642\u306e\u95a2\u9023"}